Regeneron Pharmaceuticals (REGN) Other Gross PP&E Adjustments (2010 - 2025)
Regeneron Pharmaceuticals (REGN) recorded quarterly Other Gross PP&E Adjustments of $7.2 billion in Q4 2025, up 13.7% quarter-over-quarter from $6.3 billion in Q4 2024, and up 13.7% on a YoY basis from $6.3 billion in Q4 2024.
Regeneron Pharmaceuticals (REGN) Other Gross PP&E Adjustments (2010 - 2025) Analysis & Trends
Regeneron Pharmaceuticals' Other Gross PP&E Adjustments history runs 16 years deep, the most recent figure standing at $7.2 billion for Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments rose 13.7% year-over-year to $7.2 billion; the TTM figure through Dec 2025 stood at $7.2 billion (up 13.7% YoY), while the FY2025 annual figure was $7.2 billion, up 13.7% from the prior year.
- Other Gross PP&E Adjustments was $7.2 billion for Q4 2025 at Regeneron Pharmaceuticals, up from $6.3 billion in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $7.2 billion in Q4 2025 to a low of -$15.6 million in Q3 2022.
- Historically, Other Gross PP&E Adjustments has averaged $4.7 billion across 5 years, with a median of $5.2 billion in 2022.
- The sharpest annual moves came in 2022 and 2023: Other Gross PP&E Adjustments climbed 13.25% in 2022, then climbed 14.71% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $4.2 billion in 2021, then climbed by 13.25% to $4.8 billion in 2022, then grew by 14.71% to $5.5 billion in 2023, then rose by 14.06% to $6.3 billion in 2024, then increased by 13.7% to $7.2 billion in 2025.
- The last three Other Gross PP&E Adjustments figures came in at $7.2 billion (Q4 2025), $6.3 billion (Q4 2024), and $5.5 billion (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.16 Bn |
| Dec 31, 2025 | 7.16 Bn |
| Dec 31, 2024 | 6.30 Bn |
| Dec 31, 2024 | 6.30 Bn |
| Dec 31, 2023 | 5.52 Bn |
| Dec 31, 2023 | 5.52 Bn |
| Dec 31, 2022 | 4.81 Bn |
| Dec 31, 2022 | 4.81 Bn |
| Sep 30, 2022 | -15.60 Mn |
| Sep 30, 2022 | -15.60 Mn |
| Dec 31, 2021 | 4.25 Bn |
| Dec 31, 2021 | 4.25 Bn |
| Dec 31, 2020 | 3.71 Bn |
| Dec 31, 2020 | 3.71 Bn |
| Dec 31, 2019 | 3.15 Bn |
| Dec 31, 2019 | 3.15 Bn |
| Sep 30, 2019 | -663.70 Mn |
| Sep 30, 2019 | -663.70 Mn |
| Jun 30, 2019 | -667.30 Mn |
| Jun 30, 2019 | -667.30 Mn |